I-CARE 2 study on IBD, cancer and serious infections
Part of Digestive system clinical trials.
This study follows adults with Crohn's disease, ulcerative colitis, or unclassified IBD to better understand the links between these conditions, cancer, and serious infections. It asks you to share personal details and complete online surveys over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Crohn's disease, ulcerative colitis, or unclassified IBD (confirmed by standard tests).
- You are 18 years or older.
- You agree to sign a consent form and provide your phone number and email address.
- You have regular access to the internet to fill out online surveys.
- You are not currently in another blinded clinical trial (where you don't know if you are getting the real drug or a placebo).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at ways to improve care for adults living with inflammatory bowel disease, including Crohn’s disease and ulcerative colitis. You may be invited if your clinic is part of an inflammatory bowel disease care network called IBD Qorus.
This trial collects information from children who are newly diagnosed with inflammatory bowel disease (IBD) and follows them to understand safety in real life. It may help doctors improve early diagnosis and treatment planning for kids with IBD.
This trial tests a structured IBD (inflammatory bowel disease) management program that includes incentives to help people follow care plans. It aims to improve patients’ quality of life by supporting ongoing education and follow-up.
This study tests whether people with inflammatory bowel disease (IBD) can be safely monitored from home instead of visiting the hospital every few months. It uses a smartphone app and home tests to check your condition, with fewer in-person visits.
This study is looking at how the immune system works in people with inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. By comparing blood or tissue samples from people with and without IBD, researchers hope to find better ways to treat the disease in the future.
This study looks at people with active Crohn's disease or ulcerative colitis starting a new type of medication (anti-TNF, ustekinumab, upadacitinib, or vedolizumab), as well as people without IBD having a routine colonoscopy. It aims to collect information to better understand how these treatments work.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.